Home>News & Events>Publications>C-Path>Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development1592
May 10, 2010 PRINT PDF
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
What Evidence Do We Need for Biomarker Qualification?
226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (including Biological Products) in Neonates
Preclinical Biomarker Qualification